The Risk Factors of HBV Reactivation After Conformal Radiation Therapy in Patients With Hepatocellular Carcinoma

被引：0
|
作者：
Huang, W. [1 ]
Zhang, W. [1 ]
Fan, M. [1 ]
Zhang, J. [1 ]
Li, H. [1 ]
Li, B. [1 ]
机构：
[1] Shandong Canc Hosp, Jinan, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2384
引用
收藏
页码：S368 / S368
页数：1
相关论文
共 50 条
  • [1] Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma
    Huang, Wei
    Zhang, Wei
    Fan, Min
    Lu, Yanda
    Zhang, Jian
    Li, Hongsheng
    Li, Baosheng
    [J]. CANCER SCIENCE, 2014, 105 (06) : 697 - 703
  • [2] Analysis of Hepatitis B Virus Reactivation After Conformal Radiation Therapy in Patients With Hepatocellular Carcinoma Using the Lyman NTCP Model
    Huang, W.
    Li, Z.
    Fan, M.
    Li, B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E156 - E156
  • [3] Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy
    Han, Yifan
    Liu, Jianxiang
    Pan, Jiali
    Chen, Hongyu
    Tan, Ning
    Kang, Qian
    Yang, Yuqing
    Xu, Xiaoyuan
    Li, Wengang
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Factors Associated With Overall Survival After Radiation Therapy in Patients With Hepatocellular Carcinoma
    Pi, W.
    Zang, Y.
    Zhang, H.
    Yao, H.
    Ellsworth, S.
    Long, D.
    Wang, W.
    Jin, J. Y.
    Zellars, R. C.
    Maluccio, M.
    Kong, F. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E179 - E179
  • [5] Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma
    Jang, Jeong Won
    Kwon, Jung Hyun
    You, Chan Ran
    Kim, Jin Dong
    Woo, Hyun Young
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Chung, Kyu Won
    [J]. ANTIVIRAL THERAPY, 2011, 16 (07) : 969 - 977
  • [6] Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
    Lee, Pei-Chang
    Chao, Yee
    Chen, Ming-Huang
    Lan, Keng-Hsin
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [7] Factors associated with postoperative HBV reactivation in HBV related hepatocellular carcinoma patients with HBV-DNA levels less than the minimum
    Chen, Jie
    Bai, Tao
    Wang, Xiao-Bo
    Xie, Zhi-Bo
    Liu, Jun-Jie
    Zhang, Yu
    Wu, Fei-Xiang
    Li, Le-Qun
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 4533 - 4538
  • [8] Gastrointestinal complications after radiation therapy in patients with hepatocellular carcinoma
    Yang, MH
    Lee, JH
    Choi, MS
    Park, HS
    Rhee, PL
    Kim, JJ
    Paik, SW
    Rhee, JC
    Lim, DH
    [J]. HEPATO-GASTROENTEROLOGY, 2005, 52 (66) : 1759 - 1763
  • [9] RISK FACTORS FOR THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AFTER ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS B PATIENTS
    Chen, Junjie
    Feng, Tienan
    Zhang, Xinxin
    [J]. HEPATOLOGY, 2023, 78 : S491 - S492
  • [10] Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy
    Liu, Shousheng
    Lai, Jinfa
    Lyu, Ning
    Xie, Qiankun
    Cao, Huijiao
    Chen, Dabiao
    He, Meng
    Zhang, Bei
    Zhao, Ming
    [J]. FRONTIERS IN ONCOLOGY, 2021, 10
12345